Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Flaig

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Translational Science|May 1, 2023
Clinical research reactivation during the COVID-19 pandemic: An academic center process and lessons for the futureJennifer Armstrong, Alison Lakin, Laurie Blumberg-Romero, et al.
Clinical Genitourinary Cancer|January 10, 2025
Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair MutationsStephanie Lakritz, Andrew Nicklawsky, Vida Alami, et al.
The Oncologist|June 2, 2019
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate CancerElisabeth Heath, Lance Heilbrun, Heather Mannuel, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Translational Science|May 1, 2023
Clinical research reactivation during the COVID-19 pandemic: An academic center process and lessons for the futureJennifer Armstrong, Alison Lakin, Laurie Blumberg-Romero, et al.
Clinical Genitourinary Cancer|January 10, 2025
Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair MutationsStephanie Lakritz, Andrew Nicklawsky, Vida Alami, et al.
The Oncologist|June 2, 2019
Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate CancerElisabeth Heath, Lance Heilbrun, Heather Mannuel, et al.
Pageof 2